Brief: Axogen Completes Submission of Biologics License Application to US FDA for Avance Nerve Graft

AxoGen

06/09/2024 12:05

Sept 6 (Reuters) - AxoGen Inc  AXGN.O :
    * AXOGEN COMPLETES SUBMISSION OF BIOLOGICS LICENSE
APPLICATION TO
U.S. FOOD AND DRUG ADMINISTRATION FOR AVANCE NERVE GRAFT®
    * AXOGEN INC - FDA DETERMINATION OF APPROVABILITY EXPECTED
BETWEEN
APRIL AND SEPTEMBER 2025
    * AXOGEN INC - FDA TO NOTIFY AXOGEN ON BLA REVIEW ACCEPTANCE
WITHIN 60 DAYS
    * AXOGEN INC - REQUESTS PRIORITY REVIEW STATUS FOR BLA

Source text for Eikon:  ID:nGNX5yLmSY 
Further company coverage:  AXGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))